PeptidesMasters
Start Here
EmergingCognitive Performance

Semax: What It Is, What the Research Says, and What You Need to Know

A Russian neuropeptide approved for stroke recovery and cognitive enhancement

Last updated: May 1, 2026

Educational purposes only. The information on this page is for educational and research purposes only. It does not constitute medical advice, diagnosis, or treatment. Research peptides are not FDA-approved for human therapeutic use unless explicitly stated. Always consult a licensed healthcare provider before using any compound.

What Is Semax?

Semax is a heptapeptide derived from a fragment of ACTH (adrenocorticotropic hormone). The natural ACTH fragment provides short-lived cognitive effects; Semax adds a Pro-Gly-Pro extension that dramatically increases stability and duration of action.

Approved in Russia as a prescription drug for the treatment of ischemic stroke and traumatic brain injury, Semax has a clinical track record in stroke rehabilitation settings.

Like Selank, it is typically administered as a nasal spray for rapid CNS delivery.

What Does the Research Say?

  • Russian clinical trials show improvements in neurological recovery post-stroke.
  • Studies demonstrate increased BDNF levels in brain tissue — a key neuroprotective marker.
  • Research in healthy subjects shows improved attention, working memory, and learning speed.
  • Animal studies show neuroprotection in ischemia models.
  • Western peer-reviewed evidence is sparse.

Research context: Animal studies showing positive effects do not guarantee the same results in humans. Human evidence strength varies significantly by peptide — see the Quick Stats sidebar for details.

Common Use Cases in Research

These reflect how researchers and research communities discuss this compound — not therapeutic recommendations.

  • Post-stroke neurological recovery
  • Cognitive enhancement and focus
  • Neuroprotection research
  • ADHD symptom management (anecdotal)

How It Works (Mechanism of Action)

Increases BDNF and NGF (nerve growth factor) expression in the brain, enhances dopaminergic and serotonergic neurotransmission, and improves cerebral blood flow.

Reported Benefits & Risks

Reported Benefits

Significantly improved focus and mental clarity
Enhanced memory consolidation
Neuroprotective effects
Fast onset via nasal delivery

Reported Risks

Nasal irritation
Potential overstimulation/anxiety at higher doses
Limited Western safety data
Research chemical in US

What People Ask

What does Semax feel like?

Users commonly report a noticeable improvement in focus, motivation, and mental clarity within 30–60 minutes of nasal application. Effects are described as clean (without stimulant side effects) and lasting 6–12 hours.

Legal & Regulatory Status

FDA Status

Research Only (US)

Approved in Russia for stroke. Research chemical in the US.

Cited Research

Commonly Stacked With

Research Suppliers

Affiliate link below — we may earn a commission if you purchase. This does not influence our research coverage.

View Semax Research Suppliers (affiliate link)

Related Peptides